Flexion Therapeutics, Inc. FLXN
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Flexion Therapeutics, Inc. is an American biopharmaceutical company that specializes in the discovery, development, and commercialization of innovative, locally administered therapies for musculoskeletal conditions. Founded in 2007 and headquartered in Burlington, Massachusetts, Flexion Therapeutics has built its scien…
Sector—
ExchangeNASDAQ
Industry—
CountryUnited States
Employees0
TickerFLXN
Statistics
Market Cap$1.13B
Revenue (TTM)$85.6M
Net Income-$113.7M
Net Margin-132.9%
EPS$-2.53
P/E27.35
P/S0.00
P/B-15.81
EV/EBITDA-1.38
ROE14.5%
Dividend Yield3.02%
Price$25.13
Data: Twelve Data · Revenue = mcap / P/S